Oral Generics Market: By Formulation (Tablets, Capsules, Drops, Powder, and Liquid or Syrup), By Application (Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, and Others), By Distribution Channel (Pharmacies, Hospitals, And Online Retailers), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Oral Generics Market size was valued at USD 289.4 billion in 2023 and is projected to reach USD 429.4 billion by 2030 is poised to grow at a significant CAGR 4.1 from 2024-2030. The Oral Generics Market is driven by factors such as cost-effectiveness, rising prevalence of chronic diseases, patent expirations, and government support. According to a recent report from the World Health Organization (WHO), non-communicable diseases (NCDs) such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses are taking an immense and increasing toll on lives. The report warns that if current trends continue, by around 2050, these chronic diseases will account for 86% of the 90 million deaths each year. This represents a 90% increase in absolute numbers since 2019. This is driving the demand for medications to treat these conditions, and generics offer a cost-effective way to meet this demand. Generic drugs are significantly cheaper than their brand-name counterparts, typically 30% to 80% lower, this makes them a more affordable option for patients and healthcare payers, especially as healthcare costs continue to rise, and many brand-name drugs lose their patents after a certain period, which opens the door for generic manufacturers to enter the market.

This patent expiry trend is expected to continue in the coming years, further fueling the growth of the oral generics market. Many governments around the world are actively promoting the use of generic drugs to reduce healthcare costs. This includes initiatives such as generic substitution laws, which allow pharmacists to dispense generic drugs instead of brand-name drugs if they are medically equivalent. However, the constraints of the market will hinder the growth the factors such as regulatory hurdles, quality concerns, competition, and consolidation. Yet development of complex generics, expansion into emerging markets, direct-to-consumer marketing, and focus on patient adherence are the opportunities, and increased automation, vertical integration, focus on quality, and sustainability are the trends in the oral generics market due these in upcoming years there will have a significant growth.

Oral Generics Market Key Developments:
  • In January 2022, the Medicines Patent Pool (MPP) did announce the signing of agreements with 27 generic manufacturing companies. This was to facilitate the production of the oral COVID-19 antiviral medication molnupiravir for supply in 105 low- and middle-income countries.
  • In February 2022, Oakrum Pharma, LLC, together with ANI Pharmaceuticals, made an announcement regarding the USFDA’s approval of their ANDA. This approval was for a generic form of Cystadane1, which is betaine anhydrous for oral solution, available in 180-gram bottles. Additionally, they were awarded a 180-day exclusivity period under the competitive generic therapy (CGT) designation. The introduction of such products is 

Oral Generics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Oral Generics Market Dynamics

The oral generics market growing due to the development of complex generics, such as biosimilars and controlled-release drugs, and is a growing prospect for generic manufacturers. These drugs are more difficult to develop and manufacture than traditional generics, but they can also command higher prices. Additionally, emerging markets, such as China and India, offer significant growth potential for the oral generics market and these markets have large and growing populations, and there is a growing demand for affordable healthcare products. Generic drug manufacturers are increasingly exploring direct-to-consumer marketing opportunities, and this can help to raise awareness of generic drugs and increase patient demand, there is a growing focus on improving patient adherence to medication regimens. This is a chance for generic manufacturers to develop new products and services that can help patients take their medications as prescribed. Also, generic drug manufacturers are increasingly investing in automation to improve efficiency and reduce costs, and generic drug manufacturers are vertically integrating their operations, which can give them more control over the supply chain and improve profitability. There is a growing focus on quality throughout the generic drug development and manufacturing process. This is in response to concerns about counterfeit and substandard drugs. Generic drug manufacturers are increasingly focusing on sustainability initiatives, such as reducing waste and energy consumption.

Oral Generics Market Segmentation

By Formulation

  • Tablet
  • Capsules
  • Drops
  • Powder
  • Liquid or Syrup

By Application

  • Cardiovascular Products
  • Anti-Infective Drugs
  • Anti-Arthritis Drugs
  • Others

By Distribution Channel

  • Pharmacies
  • Hospitals
  • Online Retailers

Geography

  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • The Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia & New Zealand
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • MEA
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

The oral generics market was valued at USD 289.4 billion in 2023 and is projected to grow at a significant CAGR over the forecast years to reach USD 429.4 billion by 2030.

• Cost-effectiveness
• Rising prevalence of chronic diseases
• Patent expirations.
• Government support

• Development of complex generics
• Expansion into emerging markets
• Direct-to-consumer marketing
• Focus on patient adherence

• Regulatory hurdles
• Quality concerns
• Competition
• Consolidation

Oral generics are medications that are bioequivalent to their brand-name counterparts in terms of dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. They are typically sold at a lower cost compared to brand-name drugs and contain the same active ingredients, providing the same therapeutic effects.

The report covers formulation, application, distribution channel, and region.

North America is the dominating region in the oral generics market.

Asia-Pacific is the fastest-growing region in the oral generics market.

Key Features of the Report

  • The oral generics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Oral Generics Market Introduction 
2.1.Global Oral Generics Market  - Taxonomy
2.2.Global Oral Generics Market  - Definitions
2.2.1.Formulation
2.2.2.Application
2.2.3.Distribution Channel
2.2.4.Region
3.Global Oral Generics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Oral Generics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Oral Generics Market  By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Tablet
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Capsules
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Drops
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Powder
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Liquid or Syrup
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Oral Generics Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cardiovascular Products
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Anti-Infective Drugs
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Anti-Arthritis Drugs
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Oral Generics Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Pharmacies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Retailers
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Oral Generics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Oral Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Formulation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Tablet
9.1.2.Capsules
9.1.3.Drops
9.1.4.Powder
9.1.5.Liquid or Syrup
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cardiovascular Products
9.2.2.Anti-Infective Drugs
9.2.3.Anti-Arthritis Drugs
9.2.4.Others
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmacies
9.3.2.Hospitals
9.3.3.Online Retailers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Oral Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Formulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Tablet
10.1.2.Capsules
10.1.3.Drops
10.1.4.Powder
10.1.5.Liquid or Syrup
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cardiovascular Products
10.2.2.Anti-Infective Drugs
10.2.3.Anti-Arthritis Drugs
10.2.4.Others
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmacies
10.3.2.Hospitals
10.3.3.Online Retailers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Oral Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Formulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Tablet
11.1.2.Capsules
11.1.3.Drops
11.1.4.Powder
11.1.5.Liquid or Syrup
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cardiovascular Products
11.2.2.Anti-Infective Drugs
11.2.3.Anti-Arthritis Drugs
11.2.4.Others
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmacies
11.3.2.Hospitals
11.3.3.Online Retailers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Oral Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Formulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Tablet
12.1.2.Capsules
12.1.3.Drops
12.1.4.Powder
12.1.5.Liquid or Syrup
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cardiovascular Products
12.2.2.Anti-Infective Drugs
12.2.3.Anti-Arthritis Drugs
12.2.4.Others
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmacies
12.3.2.Hospitals
12.3.3.Online Retailers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Oral Generics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Formulation Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Tablet
13.1.2.Capsules
13.1.3.Drops
13.1.4.Powder
13.1.5.Liquid or Syrup
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cardiovascular Products
13.2.2.Anti-Infective Drugs
13.2.3.Anti-Arthritis Drugs
13.2.4.Others
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmacies
13.3.2.Hospitals
13.3.3.Online Retailers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Mylan (Viatris Inc.)
14.2.2.Abbott Laboratories
14.2.3.Teva Pharmaceutical Industries Limited
14.2.4.Eli Lilly and Company
14.2.5.STADA Arzneimittel AG
14.2.6.GlaxoSmithKline PLC
14.2.7.Baxter International Inc.
14.2.8.Pfizer Inc.
14.2.9.Sanofi
14.2.10.Novartis AG (Sandoz International)
14.2.11.Sun Pharma
14.2.12.AbbVie Inc. (Allergan)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Mylan (Viatris Inc.)
  • Abbott Laboratories
  • Teva Pharmaceutical Industries Limited
  • Eli Lilly and Company
  • STADA Arzneimittel AG
  • GlaxoSmithKline PLC
  • Baxter International Inc.
  • Pfizer Inc.
  • Sanofi
  • Novartis AG (Sandoz International)
  • Sun Pharma
  • AbbVie Inc. (Allergan)

Adjacent Markets